Lannett Files ANDA For US Advair Rival
Firm Reveals It Is Also In Negotiations Over Additional Respiratory Opportunities
Executive Summary
Lannett has become the latest company to file an ANDA for a generic rival to GSK’s Advair Diskus in the US. Meanwhile, the company has revealed that it is also exploring further respiratory opportunities.